Strober, B., Augustin, M., Tada, Y., Garg, A., Jullien, D., Gottlieb, A., Gudjonsson, J., Hu, N., Hofmann, P., Thoma, C. and Marzano, A. 2024. Effect of High-Dose Subcutaneous Spesolimab on Skin Manifestations: Results from the Pivotal Effisayil 2 Trial of Flare Prevention in Generalized Pustular Psoriasis. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s371. DOI:https://doi.org/10.25251/skin.8.supp.371.